{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:17:15Z","timestamp":1778224635918,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41431-025-01953-3","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T12:58:30Z","timestamp":1758977910000},"page":"293-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From screening to strategy: Clinical implications of COL4A3\/COL4A4 variants found in reproductive genetic testing"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5966-4096","authenticated-orcid":false,"given":"Gr\u00e1inne","family":"Butler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-8511","authenticated-orcid":false,"given":"David J.","family":"Amor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"1953_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41431-020-0685-x","volume":"29","author":"EP Kirk","year":"2021","unstructured":"Kirk EP, Ong R, Boggs K, Hardy T, Righetti S, Kamien B, et al. Gene selection for the Australian Reproductive Genetic Carrier Screening Project (\u2018Mackenzie\u2019s Mission\u2019). Eur J Hum Genet. 2021;29:79\u201387.","journal-title":"Eur J Hum Genet"},{"key":"1953_CR2","doi-asserted-by":"crossref","unstructured":"Archibald A, McClaren B, Caruana J, Tutty E, King E, Halliday J, et al. The Australian Reproductive Genetic Carrier Screening Project (Mackenzie\u2019s Mission): Design and implementation. J Pers Med. 2022 Oct 28;12. Available from: https:\/\/www.mdpi.com\/2075-4426\/12\/11\/1781.","DOI":"10.3390\/jpm12111781"},{"key":"1953_CR3","unstructured":"Department of Health. Medicare Benefits Schedule 73451 [Internet]. Australian Government - Department of Health and Aged Care. 2023 [cited 2024 Jul 8]. Available from: https;\/\/www9.health.gov.au\/mbs\/fullDisplay.cfm?type=item&q=73451qt=item&criteria=73451."},{"key":"1953_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/gim.2017.134","volume":"20","author":"AD Archibald","year":"2018","unstructured":"Archibald AD, Smith MJ, Burgess T, Scarff KL, Elliott J, Hunt CE, et al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genet Med. 2018;20:513\u201323.","journal-title":"Genet Med"},{"key":"1953_CR5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/pd.6033","volume":"41","author":"S Gbur","year":"2021","unstructured":"Gbur S, Mauney L, Gray KJ, Wilkins-Haug L, Guseh S. Counseling for personal health implications identified during reproductive genetic carrier screening. Prenat Diagn. 2021;41:1460\u20136.","journal-title":"Prenat Diagn"},{"key":"1953_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","volume":"24","author":"JR Chora","year":"2022","unstructured":"Chora JR, Iacocca MA, Tich\u00fd L, Wand H, Kurtz CL, Zimmermann H, et al. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification. Genet Med. 2022;24:293\u2013306.","journal-title":"Genet Med"},{"key":"1953_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","volume":"77","author":"CE Kashtan","year":"2021","unstructured":"Kashtan CE. Alport Syndrome: Achieving Early Diagnosis and Treatment. Am J Kidney Dis. 2021;77:272\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1953_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ekir.2018.08.002","volume":"3","author":"J Savige","year":"2018","unstructured":"Savige J. Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant? Kidney Int Rep. 2018;3:1239\u201341.","journal-title":"Kidney Int Rep"},{"key":"1953_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","volume":"13","author":"A Matthaiou","year":"2020","unstructured":"Matthaiou A, Poulli T, Deltas C. Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: a systematic review. Clin Kidney J. 2020;13:1025\u201336.","journal-title":"Clin Kidney J"},{"key":"1953_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/j.ajkd.2021.02.326","volume":"78","author":"M Furlano","year":"2021","unstructured":"Furlano M, Mart\u00ednez V, Pybus M, Arce Y, Cresp\u00ed J, Venegas MDP, et al. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study. Am J Kidney Dis. 2021;78:560\u2013570.e1.","journal-title":"Am J Kidney Dis"},{"key":"1953_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.eururo.2016.03.068","volume":"70","author":"B Rocco","year":"2016","unstructured":"Rocco B, Grasso AAC, Ferraresso M, Messa PG. Re: Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. Eur Urol. 2016;70:401.","journal-title":"Eur Urol"},{"key":"1953_CR12","doi-asserted-by":"crossref","unstructured":"Savige J, Huang M, Croos Dabrera MS, Shukla K, Gibson J. Genotype-Phenotype Correlations for Pathogenic COL4A3\u2013COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome. Front Med. 2022;9. Available from: https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2022.865034.","DOI":"10.3389\/fmed.2022.865034"},{"key":"1953_CR13","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, et al. X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A \u201cEuropean Community Alport Syndrome Concerted Action\u201d Study. J Am Soc Nephrol. 2003;14:2603.","journal-title":"J Am Soc Nephrol"},{"key":"1953_CR14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","volume":"58","author":"M Levy","year":"2000","unstructured":"Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int. 2000;58:925\u201343.","journal-title":"Kidney Int"},{"key":"1953_CR15","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","volume":"32","author":"J Gibson","year":"2021","unstructured":"Gibson J, Fieldhouse R, Chan MMY, Sadeghi-Alavijeh O, Burnett L, Izzi V, et al. Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome. J Am Soc Nephrol. 2021;32:2273\u201390.","journal-title":"J Am Soc Nephrol"},{"key":"1953_CR16","doi-asserted-by":"publisher","first-page":"100631","DOI":"10.1016\/j.xkme.2023.100631","volume":"5","author":"VD Gregorio","year":"2023","unstructured":"Gregorio VD, Caparali EB, Shojaei A, Ricardo S, Barua M. Alport Syndrome: Clinical Spectrum and Therapeutic Advances. Kidney Med. 2023;5:100631.","journal-title":"Kidney Med"},{"key":"1953_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","volume":"36","author":"CE Kashtan","year":"2021","unstructured":"Kashtan CE, Gross O. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020. Pediatr Nephrol. 2021;36:711\u20139.","journal-title":"Pediatr Nephrol"},{"key":"1953_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2215\/CJN.04230321","volume":"17","author":"J Savige","year":"2022","unstructured":"Savige J, Lipska-Zietkiewicz BS, Watson E, Hertz JM, Deltas C, Mari F, et al. Guidelines for Genetic Testing and Management of Alport Syndrome. Clin J Am Soc Nephrol. 2022;17:143\u201354.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1953_CR19","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","volume":"73","author":"P Muntner","year":"2019","unstructured":"Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, et al. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019;73:e35\u201366.","journal-title":"Hypertension"},{"key":"1953_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10157-020-01880-1","volume":"24","author":"A Imafuku","year":"2020","unstructured":"Imafuku A, Nozu K, Sawa N, Nakanishi K, Ubara Y. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists. Clin Exp Nephrol. 2020;24:651\u20136.","journal-title":"Clin Exp Nephrol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01953-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01953-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01953-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:45:54Z","timestamp":1769769954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01953-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1953"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01953-3","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}